Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP Acthar Gel in Severe and Recalcitrant Keratoconjunctivitis Sicca
NCT03398018Phase 4Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2018
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in keratoconjunctivitis sicca (KCS), sponsored by University of Alabama at Birmingham. Planned start Nov 2018; status: withdrawn.
02
Drugs
repository corticotropin injection
03
Conditions
keratoconjunctivitis sicca (KCS)
Beyond the preview
Go deeper on NCT03398018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398018.